CA 72.4

The CA 72.4 test measures the concentration of the tumor-associated glycoprotein antigen CA 72.4 in serum, reported in units per millilitre (U/mL). It is a blood-based tumor marker used primarily to assist clinicians in monitoring certain gastrointestinal and ovarian malignancies by tracking changes in antigen levels over time.

CA 72.4 is most useful for follow-up during cancer treatment and for detecting possible recurrence rather than as a primary screening tool. Results are interpreted relative to a patient’s baseline values and clinical context; levels can be influenced by benign conditions, so physician correlation is essential. With home sample collection and analysis in accredited Dubai labs, patients receive fast, confidential results that support timely clinical decisions without the need to visit a clinic.

Sample handling and reporting may vary between laboratories; results are typically provided in U/mL with a laboratory-specific reference range and turnaround time (often 24–72 hours in Dubai). Discuss any medications, recent surgeries, or inflammatory conditions with your clinician before testing, and always review CA 72.4 results alongside imaging and other clinical findings for accurate management.

• CA 72.4 (Cancer antigen 72-4)
• Serum CA 72.4 concentration (U/mL)
• Sample type: Venous blood (serum)

• Baseline measurement at diagnosis of gastric or ovarian cancer
• Monitoring response to chemotherapy or other treatments
• Surveillance for disease recurrence after treatment
• When tumour marker trends are needed alongside imaging
• Unexplained clinical signs in known gastrointestinal or ovarian malignancy

• Convenient at-home blood collection by trained phlebotomists
• Analysis in accredited Dubai laboratories for reliable reporting
• Fast turnaround and secure, confidential result delivery
• Useful for tracking treatment effectiveness and detecting recurrence
• Reduces need for frequent hospital visits during follow-up

• At-home venous blood collection (serum sample) by certified staff
• No special fasting required unless instructed by your physician
• Provide relevant clinical history and current medications to the collector